Search Results - "cancer immunotherapy"

Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity by Husam Nawafleh, Nagwa Zeinelabdin, Michelle K. Greene, Anitha Krishnan, Linus Ho, Mohamed Genead, Derek Kunimoto, Christopher J. Scott, Michael Tolentino, Salem Chouaib

Connect to this object online.

Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung Cancer by Lv J, Yan W, Zhang R, Chen X, Ren Z, Chen D, Yu J

Connect to this object online.

Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade by Alaa Hamed, Doaa Ghareeb, Tarek M. Mohamed, Mahmoud Hamed, Mohammed S. Nofal, M. Gaber

Connect to this object online.

Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response by Sarabjot Pabla, R. J. Seager, Erik Van Roey, Shuang Gao, Carrie Hoefer, Mary K. Nesline, Paul DePietro, Blake Burgher, Jonathan Andreas, Vincent Giamo, Yirong Wang, Felicia L. Lenzo, Margot Schoenborn, Shengle Zhang, Roger Klein, Sean T. Glenn, Jeffrey M. Conroy

Connect to this object online.

Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer by Yaojun Yu, Jing Zhang, Leyi Ni, Yuesheng Zhu, Hejie Yu, Yangyang Teng, Limiao Lin, Zhanxiong Xue, Xiangyang Xue, Xian Shen, Haiping Song, Xiaoping Su, Weihong Sun, Zhenzhai Cai

Connect to this object online.

Aqueous Extract of Cimicifuga dahurica Reprogramming Macrophage Polarization by Activating TLR4-NF-κB Signaling Pathway by Qian S, Han X, Sha X, Tian F, Huang H, Jiang P, Huang G, Ma B, Zhang H, Zhu Y, Sun X

Connect to this object online.

Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort studyResearch in context by Antonio Farina, Macarena Villagrán-García, Anthony Fourier, Anne-Laurie Pinto, Fatima Chorfa, Noémie Timestit, Tifanie Alberto, Jérôme Aupy, Marie Benaiteau, Cristina Birzu, Lucia Campetella, François Cotton, Stéphane Dalle, Clara Fontaine Delaruelle, Pauline Dumez, Rafaele Germi, Marion Le Maréchal, Denis Maillet, Romain Marignier, Antoine Pegat, Dimitri Psimaras, Marie Rafiq, Géraldine Picard, Virginie Desestret, Isabelle Quadrio, Jérôme Honnorat, Bastien Joubert

Connect to this object online.

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies by Belen Aparicio, Patrick Theunissen, Sandra Hervas-Stubbs, Puri Fortes, Pablo Sarobe

Connect to this object online.

Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon? by Luisa Chocarro de Erauso, Miren Zuazo, Hugo Arasanz, Hugo Arasanz, Ana Bocanegra, Carlos Hernandez, Gonzalo Fernandez, Gonzalo Fernandez, Maria Jesus Garcia-Granda, Ester Blanco, Ruth Vera, Grazyna Kochan, David Escors

Connect to this object online.

Editorial: Targeting TNF/TNFR signaling pathways by Liqiang Pan, James J. Chou, Tianmin Fu

Connect to this object online.

Rheumatic immune-related adverse events from checkpoint inhibitor therapy: a case series by Antonella Laria, Alfredomaria Lurati, Laura Castelnovo, Antonio Tamburello, Paola Maria Faggioli, Antonino Mazzone

Connect to this object online.

Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches by Benjamin Ribba, Andreas Roller, Hans-Joachim Helms, Martin Stern, Conrad Bleul

Connect to this object online.

The combination therapy of oncolytic virotherapy by Yue Wang, Mengying Zhu, Mengying Zhu, Huanyu Chi, Huanyu Chi, Yang Liu, Guilin Yu

Connect to this object online.

Current Trends in Neoantigen-Based Cancer Vaccines by Szu-Ying Ho, Che-Mai Chang, Hsin-Ni Liao, Wan-Hsuan Chou, Chin-Lin Guo, Yun Yen, Yusuke Nakamura, Wei-Chiao Chang

Connect to this object online.

Human T cell glycosylation and implications on immune therapy for cancer by Elien De Bousser, Leander Meuris, Nico Callewaert, Nele Festjens

Connect to this object online.

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy by Zhaonian Hao, Ruyuan Li, Yuanyuan Wang, Shuangying Li, Zhenya Hong, Zhiqiang Han

Connect to this object online.

Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy by Zhaokai Zhou, Jiaxin Xu, Shutong Liu, Yingying Lv, Ruiqi Zhang, Xing Zhou, Yuyuan Zhang, Siyuan Weng, Hui Xu, Yuhao Ba, Anning Zuo, Xinwei Han, Zaoqu Liu

Connect to this object online.

Beyond PD-1 Immunotherapy in Malignant Melanoma by Dominika Kwiatkowska, Piotr Kluska, Adam Reich

Connect to this object online.

Opportunities and Challenges in the Delivery of mRNA-Based Vaccines by Abishek Wadhwa, Anas Aljabbari, Abhijeet Lokras, Camilla Foged, Aneesh Thakur

Connect to this object online.

Product review on the Anti-PD-L1 antibody atezolizumab by Neil J. Shah, William J. Kelly, Stephen V. Liu, Karin Choquette, Alexander Spira

Connect to this object online.